Sprint Bioscience AB (SPRINT) — Free Cash Flow Generation Index
Sprint Bioscience AB (SPRINT) has a Free Cash Flow Generation Index of 1.00x as of December 2025. Free cash flow of Skr115.78 Million represents 1% of operating cash flow (Skr115.84 Million). Explore capital reinvestment ratio of Sprint Bioscience AB to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sprint Bioscience AB Free Cash Flow Generation Index (2015–2025)
Historical FCF Generation Index trend for Sprint Bioscience AB across 4 annual periods. For the full cash flow conversion analysis, see SPRINT cash flow metrics.
Annual Free Cash Flow Generation for Sprint Bioscience AB (2015–2025)
Year-by-year Free Cash Flow Generation Index for Sprint Bioscience AB. Check Sprint Bioscience AB investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (SEK) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | Skr83.44 Million | Skr83.53 Million | Skr94.00K | ▲ +11.9% |
| 2023 | 0.89x | Skr20.42 Million | Skr22.87 Million | Skr2.45 Million | ▲ +458.9% |
| 2016 | -0.25x | Skr-1.97 Million | Skr7.93 Million | Skr9.91 Million | ▲ +96.1% |
| 2015 | -6.43x | Skr-5.36 Million | Skr833.54K | Skr6.19 Million | — |